Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

2012
type: Class

Generically Dependent Continuant
type: Class

RDF description of Methotrexate is an option for patients with refractory calcium pyrophosphate - http://research.umh.es/vivo/pub/articulo/129530
type: Document
rights: termsOfUse
date: 2026-08-14T19:49:20
publisher: Methotrexate is an option for patients with refractory calcium pyrophosphate

Methotrexate is an option for patients with refractory calcium pyrophosphate
type: Document
most specific type: 2012
page start: 234
page end: 236
related by: AutorExt:210468_2012-Artículo:129530
type: Article
related by: Autor:109288-Artículo:129530
type: Anualidad
type: Information Content Entity
type: 2012
has publication venue: JCR-J CLIN RHEUMATOL
most specific type: Academic Article
related by: AutorExt:210469_2012-Artículo:129530
ARG_2000028: 129530 vcard
date time value: 129530 pubdate
type: Continuant
type: Academic Article
type: Thing
type: Entity
type: Generically Dependent Continuant

AutorExt:210468_2012-Artículo:129530
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Methotrexate is an option for patients with refractory calcium pyrophosphate

Autor:109288-Artículo:129530
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Methotrexate is an option for patients with refractory calcium pyrophosphate

JCR-J CLIN RHEUMATOL
type: Periodical
type: Collection
type: Generically Dependent Continuant
type: Thing
type: Information Content Entity
type: Journal
type: Continuant
type: Entity
label: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
publication venue for: Methotrexate is an option for patients with refractory calcium pyrophosphate

AutorExt:210469_2012-Artículo:129530
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Methotrexate is an option for patients with refractory calcium pyrophosphate